X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/regor-initiates-phase-2-study-of-oral-once-daily-glp-1-agonist-rgt-075-for-the-treatment-of-obesity-302084213.html
https://www.prnewswire.com/news-releases/regor-announces-promising-safety-and-single-agent-efficacy-data-evaluating-rgt-419b-in-hrher2--advanced-breast-cancer-patients-who-have-progressed-on-cdk46-inhibitors-and-endocrine-therapy-302009555.html
https://www.fiercebiotech.com/biotech/regor-gets-permission-glimpse-pfizers-fbi-communique-glp-1-trade-secrets-dispute
https://endpts.com/ex-pfizer-staffers-slap-back-at-accusations-they-stole-trade-secrets-for-new-eli-lilly-partner/
https://www.pharmacompass.com/pdf/news/building-a-new-generation-ai-engine-and-jointly-accelerating-world-class-innovative-drug-discovery-and-development-1648884899.pdf
https://www.statnews.com/pharmalot/2022/02/03/pfizer-trade-secrets-diabetes-obesity/#:~:text=Pfizer%20(PFE)%20has%20accused,worth%20up%20to%20%241.5%20billion
https://www.asiaone.com/business/regor-therapeutics-announces-us-fda-authorization-conduct-regors-first-human-clinical
https://www.pharmaceutical-technology.com/news/lilly-regor-metabolic-disorders/
Market Place
Share 
